G enerally, conventional and unconventional T cells have different migratory behaviors. Conventional naive CD4
ϩ T cells, generated in thymus, migrate to secondary lymphoid tissues but not to nonlymphoid tissues (1) . They gain migratory capacity to nonlymphoid tissues when activated by Ags and dendritic cells in secondary lymphoid tissues (2) . Upon stimulation by dendritic cells, human CD4
ϩ T cells undergo chemokine receptor switch in two continuous steps (3) . CXCR3 and CXCR5 are first up-regulated and then followed by down-regulation of lymphoid tissue-homing related receptors (CCR7 and CXCR5) and concomitant up-regulation of Th1/2 effector tissuetargeting receptors such as CCR4, CCR5, CXCR6, and CRTH2. However, unconventional T cells such as CD1d-restricted NKT cells precociously gain the memory and effector phenotype when generated in thymus without having to migrate to secondary lymphoid tissues (4) . In line with this, most NKT cells express nonlymphoid tissue-homing receptors, and many NKT cells lack lymphoid tissue homing receptors such as CCR7 (5) . Some ␥␦ T cell subsets, generated early in development, directly migrate to skin and mucosal sites for immediate effector function (6, 7) .
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regulatory T cells belong to the TCR-␣␤ T cell group along with conventional CD4
ϩ or CD8 ϩ T cells and unconventional CD1d-restricted NKT cells. CD4 ϩ FOXP3 ϩ T cells are generated in thymus in response to self Ags (8 -12) . FOXP3
ϩ T cells are unconventional in that they can suppress other immune cells and play a critical role in immune tolerance (13) (14) (15) . FOXP3 ϩ T cells are also different from conventional T cells in that they are functionally competent even in thymus (16) . CD4 ϩ FOXP3 ϩ T cells are resistant to thymic deletion, and express unusual Ags such as CD25, CD5, programmed death-1, CD152 (CTLA-4), OX40, and glucocorticoid-induced TNFR (17) (18) (19) , which are often expressed by subsets of activated T cells. FOXP3 ϩ or CD4 ϩ CD25 ϩ T cells can directly suppress CD4 ϩ T cells (20), CD8 ϩ T cells (21), NKT cells (22), dendritic cells (23), monocytes/macrophages (24), and B cells (25) via largely unknown mechanisms that involve physical cell-cell contact. Trafficking receptors are thought to be important also for migration and function of FOXP3 ϩ T cells. It has been reported that CD4 ϩ CD25 ϩ T cells express high levels of CXCR4, CCR4, CCR5, CCR8, E/P-selectin ligands, and CD103 (26 -33). They also express homing receptors for lymphoid microenvironments such as CD62L, CCR7, and CXCR5 (34). CD18 (a subunit of the integrin LFA-1) is implicated in generation and function of regulatory T cells (35) .
While chemokine receptors are important for T cell migration, it has been unclear how they are regulated in FOXP3 ϩ T cells. We systematically investigated chemokine receptors and adhesion molecules of FOXP3 ϩ T cell subsets in the human circulation and secondary lymphoid tissues using FOXP3 as the major marker. We found multiple subsets of FOXP3 ϩ T cells, which characteristically express trafficking receptors according to their stage of differentiation and activation. We also demonstrated that human FOXP3 ϩ T cells undergo a switch in trafficking receptors from lymphoid to more diverse lymphoid and nonlymphoid homing receptors upon activation and differentiation, a feature potentially important for tissue-specific migration of the FOXP3 ϩ T cell subsets in humans.
Materials and Methods

Cell preparation and culture
Mononuclear cells were prepared by density gradient centrifuge on Histopaque 1077 (Sigma-Aldrich) from human peripheral blood and tonsils. T cells were enriched from blood or tonsil mononuclear cells by a sheep-RBC rosetting method (36) . This enriched T cell fraction or CD4 ϩ T cells isolated by CD4 ϩ T cell isolation kit (Miltenyi Biotec) were used for fluorescent Ab staining, chemotaxis, and intracellular cytokine assays. The use of human peripheral blood and tonsils for this study has been approved by the institutional review board at Purdue University. In some experiments, neonatal cord blood CD45RA ϩ CD4 ϩ T cells (isolated by depletion of CD45RO ϩ T cells) were activated with PHA (5 g/ml) and IL-2 (200 U/ml) for 3 days and further cultured in the presence of IL-2 for 3 more days for differentiation.
Chemotaxis of FOXP3
ϩ and FOXP3 Ϫ T cells
All chemokines were obtained from R&D Systems or PeproTech, and initially titrated to determine optimal concentrations. A total of 5 ϫ 10 5 mononuclear cells in 100 l was placed in each Transwell insert (5-m pore, 24-well format; Corning Costar). Transwell inserts were placed in 24-well plates containing 600 l of chemotaxis medium (RPMI 1640 with 0.5% BSA), with or without CCL2 (50 ng/ml), CCL4 (300 ng/ml), CCL17 (1000 ng/ml), CCL19 (2000 ng/ml), CCL20 (2000 ng/ml), CXCL10 (1000 ng/ml), CXCL12 (100 ng/ml), CXCL13 (3000 ng/ml), or CXCL16 (2500 ng/ml). Cells were allowed to migrate for 3 h in a 5% CO 2 incubator at 37°C. 
Intracellular cytokine staining
Intracellular staining was performed as described previously (37 
Immunohistochemistry
Frozen sections of tonsils were acetone-fixed and stained by monoclonal anti-FOXP3 (236A/E7) or mouse control IgG1 (eBioscience). Anti-mouse IgG-biotin (Vector Laboratories) and streptavidin-allophycocyanin (BD Biosciences) were used to assess the expression of FOXP3. Frozen sections were further stained with anti-CD45RO-FITC or PE together with antiIgD-FITC or anti-CD11c-PE (BD Biosciences) to visualize follicles vs T cell areas or dendritic cells respectively.
Statistical analyses
Student's paired two-tailed t test was used. Values of p Յ 0.05 were considered significant. All error bars shown in this paper are SEM.
Results
Circulating FOXP3 ϩ and FOXP3 Ϫ T cells: overall trafficking receptor phenotype
Trafficking receptors such as chemokine receptors and adhesion molecules regulate T cell migration to various organs. These receptors are also useful indicators for T cell differentiation and function (38, 39 
73. the expression of CD25, CD44, CD49f, CD45RO, and CD152 but are distinguished by differential expression of CD45RB and CD58.
Cytokine production capacity of CD45RA ϩ and
cells in adult peripheral blood
Effector cytokines such as IFN-␥, IL-13, and IL-10 are characteristically produced by distinct T cell subsets, namely Th1, Th2, and T regulatory type 1 (or Tr1) cells, respectively. Unlike other T cells, it is known that CD4 ϩ CD25 ϩ regulatory T cells in humans and mice cannot produce IL-2, and the master transcription factor FOXP3 (called FoxP3 in mice) suppresses IL-2 expression in regulatory T cells (40 -42) . We examined the cytokine production capacity of CD45RA ϩ , and CD45RA
Ϫ FOXP3 ϩ T cells in human blood (Fig. 2C) . As expected, FOXP3
ϩ T cells, regardless of whether they were CD45RA ϩ or CD45RA Ϫ , were largely defective in production of IL-2. Few FOXP3 ϩ T cells produced IFN-␥, a Th1 cytokine. In contrast, many CD45RA
Ϫ , but not CD45RA ϩ FOXP3 Ϫ T cells, produced IL-2, IL-13, and IFN-␥. CD45RA
Ϫ FOXP3 ϩ T cells were better than CD45RA ϩ FOXP3 ϩ T cells in production of TNF-␣. In contrast, many CD45RA
ϩ , but not CD45RA Ϫ FOXP3 ϩ T cells were able to produce TNF-␤ (also called LT-␣, a subunit that is mainly produced by naive T cells and forms LT-␣ 1 ␤ 2 and LT-␣ 3 (43, 44) ). The expression level of intracellular CD154 (CD40L, a costimulation molecule) was high in CD45RA Ϫ FOXP3 Ϫ T cells (ϳ54% are CD154 ϩ ), but it was low in CD45RA Ϫ FOXP3 ϩ T cells (Table I ). These results show that both CD45RA ϩ and CD45RA Ϫ FOXP3 ϩ T cell subsets largely lack the production capacity of IL-2 and Th1/2 cytokines, and they are different in the production capacity of TNF-␤. 
CD4
ϩ T cells express CCR7 and CXCR4, while CD45RA Ϫ T cells express memory/effector type chemokine receptors such as CCR2, CCR4, CCR5, CCR6, CCR7, CXCR3, CXCR4, CXCR5, and CXCR6. Among these, CCR4 is expressed by many Th2 cells, while CCR5, CXCR3, and CXCR6 are expressed by many Th1 cells. Many CD45RA Ϫ T cells retain CCR7 and CXCR4, while some lose expression of these receptors for migration to nonlymphoid tissues. As shown in Fig. 1 
Chemotactic behavior of CD45RA
ϩ and CD45RA Ϫ FOXP3 ϩ
T cell subsets
We further determined the function of chemokine receptors expressed by CD45RA ϩ and CD45RA Ϫ FOXP3 ϩ T cells in chemotactic response (Fig. 4) 
CD4
ϩ T cells in neonatal cord blood are CD45RA ϩ (Fig. 5 ). 1.5-5% of CD4 ϩ T cells were FOXP3 ϩ T cells (n ϭ 9). The majority (on average 79%, n ϭ 9) of neonatal cord blood FOXP3 ϩ T cells were CD45RA ϩ , but unexpectedly, significant numbers (on average 21%, n ϭ 9) of CD45RA Ϫ
FOXP3
ϩ T cells were also present in neonatal blood. Both Ϫ subsets, and they share the expression of CD25, CD152, and CD49f but are distinguished by different expression levels of CD45RO, CD45RB, and CD58.
Regulation of lymphoid and nonlymphoid tissue trafficking receptors on CD45RA
ϩ and CD45RA
cells in neonatal blood
We examined expression of chemokine receptors and adhesion molecules on CD45RA ϩ and CD45RA Ϫ FOXP3 ϩ T cells in neonatal cord blood (Fig. 5C) (Fig. 6B) . All of the four FOXP3 ϩ T cell subsets lacked the production capacity of IL-2 upon stimulation, while FOXP3 Ϫ T cells were able to produce IL-2 (Fig. 6C ). In contrast, many IL-10 ϩ cells were detected within the FOXP3 ϩ T cell population at stage III. Again, TNF-␤ was better produced by CD45RA ϩ FOXP3 ϩ cell subsets. Frozen tonsil sections were examined for microenvironmental localization of CD45RA ϩ and CD45RO ϩ FOXP3 ϩ T cells. CD45RO and FOXP3 were used as cell markers to distinguish
ϩ cells. As shown in Fig. 6 , D-I, CD45RO ϩ and CD45RO
Ϫ FOXP3 ϩ T cell subsets were frequently detected in the interfollicular area. Generally, CD45RO
ϩ FOXP3 ϩ T cells were found in the areas where CD45RO ϩ FOXP3 Ϫ T cells were located (area "a"). CD45RO
Ϫ FOXP3 ϩ T cells were often found where few CD45RO ϩ (FOXP3 ϩ or FOXP3 Ϫ ) T cells were found (area "b"). CD45RO
ϩ FOXP3 ϩ T cells were found close to where many CD11c ϩ dendritic cells were located (area "a"). In contrast, CD45RO Ϫ FOXP3 ϩ T cells were more frequently found where few CD11c ϩ dendritic cells were located (area "b"). Most CD45RA ϩ CD69 Ϫ FOXP3 ϩ T cells (stage I) expressed lymphoid tissue homing receptors, CD62L, CXCR4, and CCR7 (Fig. 7) . Precocious up-regulation of CXCR5 by ϳ30% of CD45RA ϩ FOXP3 ϩ cells was detected. Expression of memory type receptors, CCR4 and CXCR3 at low frequencies (Ͻ10%), was detected at as early as stage II (CD45RA ϩ CD69 ϩ ). At a CD45RA
Ϫ stage (III), the majority of FOXP3 ϩ T cells expressed CCR4, CCR5, CCR6, CXCR3, CXCR5, and CXCR6. At CD45RA Ϫ CD69 Ϫ stage (IV), many FOXP3 ϩ T cells down-regulated CXCR5 (a homing receptor for B cell zone and germinal centers) and CXCR6, but retained CCR4, CCR5, CCR6, and CXCR3. Down-regulation of CCR7, CXCR4, and CD62L at stage III was obvious for FOXP3 ϩ T cells. We performed chemotaxis assays to chemokine ligands to assess the function of the chemokine receptors expressed by tonsil FOXP3 ϩ cells (Fig. 8) . CD45RA Ϫ FOXP3 ϩ T cells (stages III and IV) had strong chemotactic response to a group of memory/effector chemoattractants: CCL2 (a CCR2 ligand), CCL4 (CCR5), CCL17 (CCR4), CCL20 (CCR6), CXCL10 (CXCR3), CXCL13 (CXCR5), and CXCL16 (CXCR6). The responses to lymphoid tissue chemoattractants, CCL19 (CCR7) and CXCL12 (CXCR4), were high at stage I and II but slightly weaker at stage III and IV. There were statistically significant differences between FOXP3 ϩ and FOXP3
Ϫ T cells in chemotactic responses to CCL4, CCL17, CCL20, CXCL10, and CXCL16, where FOXP3 ϩ T cells were more responsive to the memory/effector chemokines examined. Overall, the chemotactic response of FOXP3 ϩ T cells is consistent with their expression pattern of chemokine receptors, and suggests that FOXP3
ϩ T cells change their chemotactic behavior during activation and differentiation in secondary lymphoid tissues.
Differentiation-dependent switch of trafficking receptors by FOXP3
ϩ T cells
Differential expression of trafficking receptors by CD45RA ϩ , and CD45RA
Ϫ FOXP3 ϩ T cell subsets in the (neonatal and adult) blood circulation and tonsils suggests the possibility of a switch in expression of trafficking receptors during FOXP3 ϩ T cell differentiation. To demonstrate that FOXP3 ϩ T cells acquire more diverse chemokine receptors beyond secondary lymphoid tissuehoming receptors during their differentiation, partially purified cord blood CD45RA ϩ CD4 ϩ T cells containing FOXP3 ϩ and FOXP3
Ϫ cells were cultured for 3 days in the presence PHA and IL-2 followed by resting in IL-2 for 3 additional days. Anti-FOXP3 and anti-CD45RO Abs were used to identify CD45RO ϩ FOXP3 ϩ T cells after culture. After culture, most cells became CD45RO ϩ cells. While neonatal CD45RA ϩ FOXP3 ϩ T cells did not express memory, Th1 or Th2 chemokine receptors, in vitro differentiated CD45RO ϩ CD45RA Ϫ FOXP3 ϩ T cells up-regulated CCR2, CCR4, CCR5, CCR6, CXCR3, CXCR5, and CXCR6 (Fig. 9) . Down-regulation of CCR9 and ␣ 4 ␤ 7 on memory FOXP3 ϩ T cells was detected in a manner similar to FOXP3 ϩ T cells circulating in adult and neonatal blood (Figs. 3 and 5) . However, the in vitro differentiated CD45RO ϩ FOXP3 ϩ T cells still retained CCR7 and CXCR4. Overall, there was clear evidence that human CD45RA ϩ FOXP3 ϩ T cells undergo chemokine receptor switch during their differentiation to CD45RO ϩ cells.
Discussion
The human CD4 ϩ TCR-␣␤ T cell population is composed of functionally distinct conventional T cell subsets such as naive, memory, Th1, Th2 and B cell-helping T cells, and regulatory T cells exemplified by FOXP3
ϩ T cells (8 -12, 45) . Functionally specialized T cell subsets express different trafficking receptors, which is important for their migration to appropriate tissue sites (46) . We thoroughly examined, ex vivo, the existence of distinct subsets of FOXP3 ϩ T cells in expression of trafficking receptors in humans and demonstrated their change in expression of chemokine receptors during differentiation in vitro. Our results revealed that human FOXP3 ϩ cells undergo trafficking receptor switch from CXCR4, CCR7 and CD62L (secondary lymphoid tissue homing receptors) to more diverse nonlymphoid tissue homing related receptors upon activation and differentiation.
We show in this study the presence of distinct subsets of human FOXP3 ϩ T cells defined by differentiation/activation-related surface Ags (CD45RA, CD45RO, CD69, and many others) and trafficking receptors. It was initially reported that CD4
ϩ CD25 ϩ T cells in adult blood expressed CD45RO but not CD45RA, and, thus, the whole population was considered memory T cells (47, 48) . This interpretation was probably due to the fact that CD25 was used instead of FOXP3 as the marker of regulatory T cells, and that CD45RA ϩ FOXP3 ϩ T cells constitute a minor population compared with CD45RA
Ϫ FOXP3 ϩ T cells in adult peripheral blood. Moreover, the presence of naive (CD45RA ϩ ) and memory (CD45RO ϩ ) regulatory T cells with comparable suppressor activity at various stages of human development was recently confirmed (49 -51) . The CD45RA Ϫ FOXP3 ϩ T cells in adult blood have all the features of memory/effector T cells in surface phenotype and trafficking receptors, but they largely lack the production capacity of CD154, IL-2 and Th1 and Th2 cytokines, as expected. We found that CD45RA ϩ and CD45RO ϩ FOXP3 ϩ T cell subsets are different from each other in expression of CD58 and TNF-␤ (also called LT-␣). While the functional significance of this difference remains to be determined, CD58 and TNF-␤ appear to be useful Ags for identification of different FOXP3 ϩ T cell subsets. Most CD45RA ϩ FOXP3 ϩ T cells in adult blood are CD45RB high and CD45RO Ϫ as expected but some of these cells atypically coexpress CD45RO (Fig. 2) (Fig. 6 ). This is consistent with the similarity in trafficking receptor expression between CD45RA ϩ FOXP3 Ϫ and CD45RA ϩ FOXP3 ϩ T cells or between CD45RO ϩ FOXP3 Ϫ and CD45RO ϩ FOXP3 ϩ T cells (Fig. 7) . CD45RA ϩ FOXP3 ϩ T cells and CD45RO ϩ FOXP3 ϩ T cells, found in dendritic cell-rich areas, are likely to be the FOXP3 ϩ T cells undergoing Ag priming and trafficking receptor switch.
We were able to reproduce the trafficking receptor switch in vitro using cord blood T cells (Fig. 9) Ϫ T cells, as it has been reported that FOXP3 expression can be induced in certain conditions (53) . The trafficking receptor switch occurring in vitro mimics that occurring in vivo in upregulation of memory and inflammatory tissue-homing related receptors. A slight deviation from the phenotype of FOXP3 ϩ T cells in peripheral blood was the lack of down-regulation of CCR7 and CXCR4 on in vitro primed FOXP3 ϩ T cells (Fig. 9 ). The FOXP3 ϩ T cells, Ag-primed in vitro, were rather similar to resting CD45RO ϩ FOXP3 ϩ T cells in tonsils which express both lymphoid and nonlymphoid tissue-associated trafficking receptors at high frequencies.
Taken together, our results revealed both unconventional and conventional characteristics of FOXP3 ϩ T cells and provide insights into their differentiation and trafficking potentials in the human body. The fact that CD45RA
Ϫ FOXP3 ϩ T cells with nonlymphoid tissue trafficking receptors appear as early as at birth is unconventional. By expressing the complete set of lymphoid homing receptors (CD62L, CCR7, and CXCR4), CD45RA ϩ FOXP3 ϩ T cells have the trafficking receptor phenotype for secondary/mucosal lymphoid tissues. CD45RA Ϫ FOXP3 ϩ T cells have the trafficking receptor phenotype for nonlymphoid and inflamed tissue sites (CLA, CCR2, CCR4, CCR5, CCR6, CXCR3, and CXCR6). While the majority of CD45RA Ϫ FOXP3 ϩ T cells retain CCR7, the loss of CCR7 (and CXCR4) and up-regulation of CXCR5 on activated CD45RA
Ϫ FOXP3 ϩ T cells may be important for their positioning in secondary lymphoid tissues. We conclude that human FOXP3 ϩ T cells undergo trafficking receptor switch during the differentiation from CD45RA ϩ to CD45RA Ϫ cells (Fig. 10 ). This differentiation program is potentially important for tissue-specific migration and function of FOXP3 ϩ T cell subsets in humans. 
